| Literature DB >> 34117528 |
Markus Feldkötter1, Sarah Thys2, Anne Adams3, Ingrid Becker3, Rainer Büscher4, Martin Pohl5, Raphael Schild6, Lars Pape7, Claus Peter Schmitt8, Christina Taylan9, Simone Wygoda10, Günter Klaus11, Henry Fehrenbach12, Carmen Montoya13, Martin Konrad14, Heiko Billing15, Bettina Schaar2, Bernd Hoppe16,17.
Abstract
OBJECTIVE: Pediatric patients spend significant time on maintenance hemodialysis (HD) and traveling. They are often not capable of participating in sports activities. To assess the effects of exercise training during HD on dialysis efficacy in children and adolescents, we set up a multi-center randomized controlled trial (RCT).Entities:
Keywords: Adolescents; Children; Endurance training; Hemodialysis; Sport; spKt/V
Mesh:
Year: 2021 PMID: 34117528 PMCID: PMC8599370 DOI: 10.1007/s00467-021-05114-8
Source DB: PubMed Journal: Pediatr Nephrol ISSN: 0931-041X Impact factor: 3.714
Fig. 1Study schedule: After screening and randomization of the patient, three times weekly bicycle ergometer training during hemodialysis for up to 50 to 70 min (warm up, endurance training, cool down) duration and with 70–80% of the patient-specific maximum workload during 12 weeks was performed twice in the intervention group (periods I and II). In the waiting control group, no ergometer training was performed during the first 12 weeks (period I); training was then performed in intervention period II
Fig. 2Patient flow intention-to-treat (ITT) population
Fig. 3Patient flow per-protocol (PP) population
Single-pool Kt/V data V0–V2 (ITT population)
| Intervention group | Control group | ||
|---|---|---|---|
| V0 | 1.70 (0.33) | 1.80 (0.55) | 0.4922 |
| V1 | 1.70 (0.36) | 1.71 (0.51) | 0.9081 |
| V2 | 1.70 (0.36) | 1.86 (0.56) | 0.3605 |
Fig. 4Primary endpoint: Mean single-pool Kt/V at different testing points, ITT (intention-to-treat population), LOCF (last observation carried forward). V0 baseline, V1 post first intervention period (12 weeks), V2 post second intervention period (24 weeks)
Primary endpoint and secondary endpoints (V1 vs. V0) in the intention-to-treat (ITT) population (value and in brackets standard deviation)
| Training group (TG) | Control group (CG) | ||||
|---|---|---|---|---|---|
| V0 | V1 | V0 | V1 | ||
| Primary endpoint | |||||
| Single-pool Kt/V | 1.70 (0.33) | 1.70 (0.36) | 1.80 (0.55) | 1.71 (0.51) | 0.2245 |
| Secondary endpoints | |||||
| Possible workload (max. physical performance) | |||||
| Maximum power (watt) | 78.6 (27.4) | 83.8 (32.5) | 77.8 (21.5) | 79.2 (23.6) | 0.1699 |
| Pulse (1/min) | 83.7 (19.4) | 83.6 (19.1) | 81.1 (16.4) | 87.3 (16.3) | 0.0799 |
| Quality of life (PedsQL) | |||||
| Total score parents | 69.7 (21.2) | 74.0 (11.7) | 75.0 (15.4) | 81.2 (7.1) | 0.3204 |
| Total score child | 74.9 (15.7) | 77.8 (12.3) | 81.3 (11.8) | 80.1 (10.9) | 0.2853 |
| Change of solute removal during HD | |||||
| Reduction of urea (%) | 73.0 (6.8) | 76.2 (8.0) | 74.6 (10.3) | 74.4 (8.4) | 0.5133 |
| Reduction of creatinine (%) | 66.8 (8.0) | 69.1 (9.3) | 68.4 (10.9) | 67.5 (9.0) | 0.5110 |
| Reduction of phosphate (%) | 40.8 (42.7) | 55.7 (13.1) | 41.9 (38.5) | 42.7 (36.6) | 0.0869 |
| Reduction of potassium (%) | 27.6 (9.7) | 25.8 (7.6) | 26.8 (12.5) | 24.6 (11.3) | 0.9054 |
| Change of solute removal in a two compartment model (TG | |||||
| Double-pool Kt/V | 1.5 (0.22) | 1.5 (0.26) | 1.4 (0.39) | 1.5 (0.39) | 0.4985 |
| Change in inflammation | |||||
| C-reactive protein (mg/L) | 4.0 (10.9) | 2.3 (3.2) | 4.2 (5.9) | 3.7 (4.6) | 0.8253 |
| Nutritional status and bone metabolism | |||||
| Albumin (g/L) | 43.2 (3.3) | 41.4 (5.5) | 43.0 (3.3) | 43.2 (3.3) | 0.3115 |
| Alkaline phosphatase (U/L) | 179.2 (92.0) | 179.9 (99.4) | 204.4 (111.7) | 231.5 (179.5) | 0.9104 |
| Parathyroid hormone (PTH) (ng/L) | 282.3 (224.4) | 318.4 (206.8) | 229.9 (167.1) | 250.8 (220.7) | 0.6012 |
| Body composition monitoring | |||||
| Total body water (L) | 28.0 (9.9) | 27.1 (9.1) | 26.1 (5.9) | 26.2 (7.0) | 0.8396 |
| Fat-free mass (kg) | 17.8 (2.6) | 17.7 (3.8) | 17.2 (0.9) | 21.1 (6.9) | 0.4459 |
| Fat mass (kg) | 9.7 (7.4) | 9.4 (7.1) | 9.5 (6.4) | 10.0 (5.7) | 0.8406 |
| Overhydration (L) | 0.8 (1.6) | 0.9 (1.1) | 1.0 (1.0) | 0.9 (1.4) | 0.8467 |
Fig. 5Exemplary secondary endpoint: mean elimination of low molecular substances—no changes between V0 and V2 for blood urea, serum creatinine, serum phosphate, and mean double-pool Kt/V
Baseline patient characteristics in DiaSport according to intervention and waiting control group
| Characteristics | Intervention group | Waiting control group | |
|---|---|---|---|
| 23 | 22 | ||
| Gender | |||
| Male | 19 | 13 | 0.1075 |
| Female | 4 | 9 | |
| Prior kidney transplantation | |||
| No | 18 | 16 | 0.7381 |
| Yes | 5 | 6 | |
| Dialysis therapy | |||
| < 1 year | 18 | 16 | 0.1159 |
| > 1 year | 5 | 6 | |
| Dialysis access | |||
| Catheter | 4 | 6 | 0.6937 |
| AV fistula | 17 | 15 | |
| Both | 2 | 1 | |
| Age | |||
| < 12 years | 6 | 2 | 0.2427 |
| > 12 years | 17 | 20 | |
| Mean age, years (SD) | 14.0 (3.44) | 15.1 (2.45) | 0.2286 |
| Height, cm (SD) | 153.8 (21.34) | 155.6 (15.68) | 0.7411 |
| Weight, kg (SD) | 48.1 (18.16) | 45.6 (12.50) | 0.5940 |
| BMI, kg/m2 (SD) | 19.6 (4.03) | 18.5 (2.41) | 0.2576 |
| Single-pool Kt/V (SD) | 1.70 (0.33) | 1.79 (0.55) | 0.4922 |
| Reduction of phosphate, (%) (SD) | 40.8 (42.73) | 41.9 (38.50) | 0.9273 |
| Hemoglobin, g/dL (SD) | 11.2 (1.71) | 11.2 (1.33) | 0.9138 |